ISDS Case Map
intellectual property
Civil society and public health groups from India, Brazil and several other countries today vehemently objected to the proposed India-European Union Free Trade Agreement (FTA).
In a report submitted to the United Nations Human Rights Council over the weekend, PIJIP joined with HIV treatment advocacy organizations Health Global Access Project (HealthGAP) and the European Community Advisory Board to call for a human rights review of U.S. trade policy on access to medicines.
Suspicions persist over a link between the Anti-Counterfeiting Trade Agreement (ACTA) and negotiations for international free-trade pacts, despite efforts by officials to downplay the issue.
Tough intellectual property rights sought by the EU in its free trade agreement with India have set off global protests
With the Wellington round of the controversial Anti-Counterfeiting Trade Agreement (ACTA) talks underway, organised opposition to the proposed treaty on intellectual property rights and enforcement is also gathering in the New Zealand capital. A brief chat with a global expert on the ACTA treaty.
Officials negotiating New Zealand’s position on the Anti-Counterfeiting Trade Agreement (ACTA) intellectual-property treaty say they have no perspective on the separate negotiations over the Trans-Pacific Partnership trade agreement. Nor would they be involved in any trade-off of ACTA concessions against broader free-trading rights.
A new accord designed to bolster political and economic ties between the European Union and Central America could result in greater seizures of medicines whenever pharmaceutical companies allege that their patents have been infringed, public health advocates have warned.
Michael Geist has leaked the lasted draft of the intellectual property chapter of the Canada-EU Comprehensive Economic Trade Agreement. These are some brief comments on the new document.
The Delhi Network of Positive People (DNP+) is calling on the EU Trade Commissioner to come clean on the demands and pressures being placed by the European Union on the Government of India to accept TRIPS-plus measures that will have a severe, adverse impact on access to safe, effective and affordable medicines in India and across the developing world.
A group of nine Georgetown Law students have written a report, "Prescription for Failure: Health and Intellectual Property in the Dominican Republic," which finds that U.S. efforts to increase intellectual property protections in the Dominican Republic may lead to sharp increases in the cost of lifesaving drugs and, as a result, the declining health and even deaths of those who may be unable to afford them.
